Metabolomic Signatures of MASLD Identified by the Fatty Liver Index Reveal Gamma-Glutamyl Cycle Disruption and Lipid Remodeling
Background/Objectives: Metabolic dysfunction-associated steatotic liver disease (MASLD) is the most prevalent chronic liver disorder worldwide and a key driver of cardiometabolic complications. Despite its growing burden, the underlying metabolic perturbations remain incompletely understood. The Fat...
Guardat en:
| Autors principals: | , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2025-10-01
|
| Col·lecció: | Metabolites |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/2218-1989/15/11/687 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|